Tag: epilepsy

Physicians Educational Resource

Physicians’ Education Resource releases agenda for the 1st Annual International Congress...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on...

NeuroPace present positive data from studies of the RNS System

NeuroPace has presented long-term clinical results demonstrating that the RNS System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Less-invasive procedure helps surgeons pinpoint epilepsy surgical candidates

A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better...

Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim

At the recent American Epilepsy Society Annual Meeting in New Orleans, USA, Neuroelectrics presented positive results from its clinical trial treating patients with drug...

Medtronic’s deep brain stimulation for medically-refractory epilepsy launches in the USA

Medtronic has announced both the US launch of deep brain stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University...

NeuroPace announces new Category I CPT code for the RNS system

NeuroPace has announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT) code for electrocorticography from an implanted...
Medtronic logo

Medtronic receives FDA Approval for deep brain stimulation therapy for medically...

The US Food and Drug Administration (FDA) has granted premarket approval for Medtronic's deep brain stimulation (DBS) therapy as adjunctive treatment for reducing the...

NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...

NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...

FDA approves SenTiva device for treatment of epilepsy

LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...

LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling

LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...

LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling

  LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling. According...

ADDRESS trial of Prometra II infusion system begins

The first patients have been implanted with the Prometra II Programmable Infusion System in the ADDRESS (Australian direct drug administration for refractory epilepsy)clinical trial at...

AAN releases new guideline on how to map brain prior to...

Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure...

Flowonix Medical and Alliance Spine and Pain Centers announce first Prometra...

Flowonix Medical and Alliance Spine and Pain Centers have announced the first implant of the Prometra II intrathecal infusion pump in Georgia, USA. The...